BI Asset Management Fondsmaeglerselskab A/S
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1778131
KOBENHAVN, G7
Position in ALNY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,136,409
+$251,443 QoQ
Shares Held
7,097
+24.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#327
of 786 holders
Holding Since
Sep 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BI Asset Management Fondsmaeglerselskab A/S holds $75,123,826 across 13 Biotechnology names. ALNY ranks #7 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
35,137 | $17,453,602 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
206,563 | $16,167,686 | |
| 3 | EXEL |
Exelixis, Inc.
|
274,867 | $14,955,513 | |
| 4 | INCY |
Incyte Corp
|
113,231 | $12,835,866 | |
| 5 | INSM |
INSMED Inc
|
46,033 | $4,908,038 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,132 | $3,200,007 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
7,097 | $2,136,409 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
25,727 | $2,039,893 |
All Filings in ALNY
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,136,409 | 7,097 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $1,884,966 | 5,697 | Shares | Defined | 2026-04-16 | |
| 2025-12-31 | $5,912,657 | 14,869 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $3,057,480 | 6,705 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $2,253,934 | 6,912 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,442,446 | 5,342 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,766,069 | 11,755 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,344,080 | 8,523 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,108,566 | 4,562 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $556,551 | 3,724 | Shares | Defined | 2024-05-03 | |
| 2023-12-31 | $721,424 | 3,769 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $299,830 | 1,693 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $419,577 | 2,209 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $2,416,259 | 12,062 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,337,969 | 5,630 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $582,265 | 2,909 | Shares | Defined | 2022-11-07 | |
| 2022-06-30 | $456,510 | 3,130 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $305,025 | 1,868 | Shares | Defined | 2022-05-11 | |
| 2020-09-30 | $42,660 | 293 | Shares | Defined | 2020-11-09 | |
| No filing history on record for this holder in this stock. | ||||||